International Journal of Cancer

Papers
(The TQCC of International Journal of Cancer is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Issue Information785
Issue Information277
229
Issue Information137
Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study124
Issue Information117
Assessment of long‐term survival in childhood cancer patients using cancer registry data from eastern China: Period analysis outperforms traditional analysis96
A comprehensive investigation of histotype‐specific microRNA and their variants in Stage I epithelial ovarian cancers80
Issue Information74
Comments on “Methylation scores for smoking, alcohol consumption and body mass index and risk of seven types of cancer”71
71
Pre‐diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study66
Improving colon cancer screening in Poland. In search of the Holy Grail66
Pan‐cancer analysis reveals molecular signatures for predicting matrix stiffness in solid tumors62
Trends in cancer incidence by socioeconomic deprivation in Germany in 2007 to 2018: An ecological registry‐based study62
Cervical cancer screening: Sharing best practices and addressing common challenges in cervical cancer screening programs61
Erratum59
Education level and risk of breast cancer by tumor subtype in the EPIC cohort57
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer57
Prenatal diethylstilbestrol exposure and risk of benign breast disease: The National Cancer Institute Diethylstilbestrol Follow‐up Study56
Ramucirumab‐containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum‐based chemotherapy: A multicenter observational retrospective study (W56
Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration d56
52
Ovarian cancer survival in sub‐Saharan Africa by human development index and histological subtypes: A population‐based registry study51
Association of aflatoxin with gallbladder cancer in a case‐control study nested within a Chinese cohort50
Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (NOWAC)48
Issue Information47
Antiviral prophylaxis for hepatitis B virus reactivation in T‐cell lymphoma patients with resolved hepatitis B virus infection47
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials46
DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target44
Timing of surgery and 1‐year postoperative outcomes in patients with breast cancer and preoperative COVID‐19 history: A matched, longitudinal, ambidirectional cohort study44
Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study44
Maternal illnesses during pregnancy and the risk of childhood cancer: A medical‐record based analysis (UKCCS)43
Longitudinal changes in health‐related quality of life after a breast cancer diagnosis in sub‐Saharan Africa: Evidence from the prospective ABC42
Celecoxib promotes the efficacy of STING‐targeted therapy by increasing antitumor CD8+ T‐cell functions via modulating glucose metabolism of CD11b+42
The cervico‐vaginal DNA methylation WIDqEC t41
Dipeptidyl peptidase‐4 in the tumor microenvironment of the digestive system: Molecular mechanisms and therapeutic targets40
Development and psychometric properties of a general cancer stigma scale40
Urokinase Plasminogen Activator Receptor‐Associated Protein ( uPARAP ) as a Potential Next Generation Molecular Target for Treatment of Gastrointesti39
Socioeconomic position and risk of cervical cancer in the Nordic countries: Results from the Nordic Occupational Cancer Study38
New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities38
Cost‐effectiveness of risk‐stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage38
Longitudinal associations of plasma metabolites with persistent fatigue among colorectal cancer survivors up to 2 years after treatment38
Household air pollution and risk of incident lung cancer in urban China: A prospective cohort study38
The German ONKOPEDIA Guideline for Myelofibrosis in 2025—Recommendations of an MPN Expert Panel of36
Body mass index and colorectal cancer recurrence and mortality: A nationwide cohort study in Denmark35
Identification of pre‐diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case‐control study within the ATBC cohort35
The current status of cell‐free human papillomavirus DNA as a biomarker in cervical cancer and other HPV‐associated tumors: A review35
Mediation effect of intestinal microbiota on the relationship between fiber intake and colorectal cancer35
Survival rates and extra‐regional migration patterns of children and adolescents with cancer in Italy: The 30‐year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) wi35
Challenges in the future of cancer screening34
International Anal Neoplasia Society's consensus guidelines for anal cancer screening34
Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization34
Colorectal Cancer Screening in Hereditary and Familial High‐Risk Populations: Best Practices and Future Directions34
Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population‐based cohort study33
Prevalence and distribution of HPV types in Australian patients with oropharyngeal cancer over time33
Changes in cancer incidence rates by stage during the COVID‐19 pandemic in the US33
HPV ‐Related Cancers in Solid Organ Transplant Recipients: A Nationwide Danish Cohort Study32
Correction to “Geographical and Spatial Disparities in the Incidence and Survival of Rare Cancers in Australia”32
Issue Information32
Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries31
Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients31
tRNA ‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression31
Mid‐ and Long‐Term Risk of Venous Thromboembolism Among Female Breast Cancer Survivors: A Nationwide Cohort Study31
Global Annualized Recurrence Rates and Dynamic Risk Profiles in Head and Neck Cancer31
Issue Information30
Issue Information30
Survival outcomes and prognostic factors of gastric carcinoma with neuroendocrine differentiation30
Prevalence and time trends of human papillomavirus in penile cancer over 26 years—A comprehensive study of 1040 penile cancer cases from Denmark30
Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population‐based patient cohort study in southern China30
Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk30
Harnessing normalcy: The potential of healthy tissue for patient outcomes29
Circulating fatty acid binding protein 4 ( FABP ‐4) concentrations and mortality in individuals with colorectal cancer in the European Prospective In29
Oral human papillomavirus (HPV) infection and HPV vaccination in an Australian cohort29
Safe prescribing in cancer patients during the COVID‐19 pandemic and outcomes following restart of cancer care following SARSCoV‐2 infection: The COV29
Issue Information29
Uncovering possible silent acquired long QT syndrome using exercise stress testing in long‐term pediatric acute lymphoblastic leukemia survivors29
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients28
Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status28
28
Comment on “Multi‐cancer early detection via a DNA methylation multiplex ddPCR‐based blood test”28
Issue Information27
Pre‐diagnostic plasma advanced glycation end‐products and soluble receptor for advanced glycation end‐products and mortality in colorectal cancer patients27
Chemotherapy‐induced neutropenia predicts short‐term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid27
27
Stereoscopic epidemiology of global cancer: Complementary lenses from GBD 2023 and GLOBOCAN 202227
Anti‐Her2 therapy patterns in metastatic breast cancer—Real‐world data suggest undertreatment27
CTHRC1 promotes bone metastasis in prostate cancer27
Incidence patterns and temporal trends of childhood cancer in Germany, 1980–2019: Forty years of childhood cancer registration in Germany26
Cost‐effectiveness of low‐dose CT lung cancer screening among individuals that have ever smoked in Norway: A model‐based analysis using 26
Erratum to “Surveillance of premalignant gastric cardia lesions: A population‐based prospective cohort study in China”26
The effect of diet and nutrition on T cell function in cancer26
Treatment landscape from first‐ to third‐line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON 26
Risk–Benefit of Phase 2 Monotherapy Trials in Adult Solid Cancers: A Systematic Review and Meta‐Analysis26
Issue Information26
Special issue “The advance of solid tumor research in China”: Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors26
Clinicopathological and genomic features of early‐onset non‐small cell lung cancer across age and ethnicity26
Combination of pimitespib (TAS‐116) with sunitinib is an effective therapy for imatinib‐resistant gastrointestinal stromal tumors26
Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004–2015: A comparative population‐based study25
Different treatment efficacies and T790M acquisition of EGFR‐TKIs on NSCLC patients with variable Del‐19 subtypes of EGFR25
FSCN1 as a new druggable target in adrenocortical carcinoma25
From non‐coding RNAs to cancer regulators: The fascinating world of micropeptides25
Erratum25
Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan25
Development and Release of the Munich UICC Staging Tool ( MUST ): Advancing 25
Deposition of onco‐histone H3.3‐G34W leads to DNA repair deficiency and activates cGAS/STING‐mediated immune responses24
Person‐years of life lost and lost earnings from cigarette smoking‐attributable cancer deaths, United States, 201924
Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvan24
Childhood acute leukemia and type 1 diabetes in children: A nationwide case–control study24
Systemic circulating microRNA landscape in Lynch syndrome24
Interventions for oral cancer prevention: An evidence and gap map24
Incidence of late recurrence and second primary cancers 5–10 years after non‐metastatic colorectal cancer24
Cancer‐related fatigue: Towards a more targeted approach based on classification by biomarkers and psychological factors24
Cost‐Effectiveness of Initiating Colorectal Cancer Screening at Age 40 Among Average‐Risk Individuals in China24
Long‐term exposure to air pollution and incidence of gastric and the upper aerodigestive tract cancers in a pooled European cohort: The ELAPSE project24
Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation24
Female reproductive and hormonal factors and lung cancer mortality among never‐smokers: A prospective cohort study of 287 408 Chinese women24
Systemic Lipid Peroxidation and Colorectal Cancer Risk: A Time‐Varying Relationship23
Multiple primary lung cancer: Updates and perspectives23
Pan‐Cancer Quantification of Driver Alteration Transmission Across Molecular Layers Reveals Limited Propagation to Protein Abundance23
Let's talk about sex: Survival among females and males in a real‐world cohort treated with pembrolizumab for non‐small cell lung cancer23
Immune checkpoint inhibitor‐induced vitiligo: A large‐scale real world pharmacovigilance study23
Efficacy and safety of 5‐aminolevulinic acid‐based photodynamic therapy for cervical low‐grade squamous intraepithelial lesions with HPV infections23
Proteomic signature for detection of high‐grade ovarian cancer in germline BRCA mutation carriers23
CXCR4 expression is associated with proneural‐to‐mesenchymal transition in glioblastoma23
Survival by Detection Pathway in Patients With Lung Cancer—A Nationwide Descriptive Epidemiological Study in Japan23
Metformin and other anti‐diabetic medication use and breast cancer incidence in the Nurses' Health Studies23
Cyanotoxin exposure as a novel risk factor for liver fibrosis and steatosis23
Exploration of immunotherapy in advanced pulmonary lymphoepithelioma‐like carcinoma22
Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium22
Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group22
Associations of Outdoor Air Pollution With Incidence of Cancers Other Than Lung Cancer in a Large US Prospective Cohort22
Serum IgG N‐glycans enable early detection and early relapse prediction of colorectal cancer22
Blood‐based biomarkers in soft tissue sarcoma: Implications for immune checkpoint inhibitor therapy22
Long‐term follow‐up of cervical cancer incidence after normal cytological findings22
Genome‐wide exploration of genetic interactions for bladder cancer risk22
Environmental Pesticide Exposure in the Etiology of Pediatric Brain Tumors and Leukemia: A Scoping Review of Epidemiological Studies22
Sex differences in cancer incidence and mortality among patients managed at King Hussein Cancer Center22
High Endothelial Venules as Conduits for Antitumor Immune Cell Trafficking in Small Cell Lung Cancer22
14‐3‐3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer22
Trends in the incidence of ovarian cancer in sub‐Saharan Africa22
DNA methylation signatures of cervical pre‐invasive and invasive disease: An epigenome‐wide association study21
Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cance21
Reply to: Comments on “Psychosocial factors, health behaviors and risk of cancer incidence: Testing interaction and effect modification in an individual participant data meta‐analysis”21
Stage‐ and histology‐specific sensitivity for the detection of lung cancer of the NELSON screening protocol—A modeling study21
Real‐world efficacy and toxicity of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma according to IMDC risk crite21
21
Prognostic impact of p16 and high‐risk HPV DNA in ~1300 patients with vulvar cancer21
DNA methylation landscape of tumor‐associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple‐negative breast cancer patients21
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)‐induced phenotypes for platinum sensitivity and long‐term su21
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐lif20
Comparative sequencing study of mismatch repair and homology‐directed repair genes in endometrial cancer and breast cancer patients from Kazakhstan20
Underdiagnosed cancer during COVID‐19 pandemic and return to normality20
Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts20
A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure20
Coffee consumption is associated with a reduced risk of colorectal cancer recurrence and all‐cause mortality20
Mutational evolution after chemotherapy‐progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis20
Incidence of cancer among Nordic police officers20
KMT2D links TGF ‐β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity20
Combination of PD‐1/PD‐L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma20
Issue Information20
The United States experience with diagnosing and treating esophageal cancer during the SARS‐CoV‐2 pandemic: A retrospective cohort study20
Comments on the paper “Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple‐negative breast cancer” by Y. Chen et al.20
Blood‐Based Circulating Tumor DNA Assays for Early Colorectal Cancer Detection: A Systematic Review of Performance in Asymptomatic Screening Populati20
Rewriting the MASLD ‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism19
Time intervals in the care pathway to cancer diagnosis during the COVID‐19 pandemic: A large retrospective study from a high‐volume center19
Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune‐related adverse events during treatment with immune checkpoint inhibitors19
Genome‐wide study of genetic polymorphisms predictive for outcome from first‐line oxaliplatin‐based chemotherapy in colorectal cancer patients19
Evaluation of methods to identify chemotherapy‐related hematologic toxicities in real‐world settings19
Reply to: Comments on “Associations of plasma omega‐6 and omega‐3 fatty acids with overall and 19 site‐specific cancers: A population‐based cohort study in UK Biobank”19
How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation19
Issue Information19
Reproductive history and breast cancer survival: Findings from the African breast cancer—Disparities in outcomes cohort and implications of Africa's fertility transition on breast cancer prognosis19
Sex‐ and site‐specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort19
Correction to “Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization”19
Cumulative risks of false positive recall and screen‐detected breast cancer after multiple screening examinations19
Fetal growth and pediatric cancer: A pan‐cancer analysis in 7000 cases and 37 000 controls19
Cigarette smoke induces expression of senescence markers and pro‐inflammatory SASP in oral mucosa: Potential implications for early carcinogenic proc18
Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo‐refractory gastrointestinal cancers18
Comparing outcomes and toxicities among patients with nasopharyngeal carcinoma treated with daytime versus evening radiotherapy: A retrospective analysis with propensity score matching18
Risk factors for low‐risk prostate cancer: A retrospective cohort study within the FinRSPC trial18
Drug repurposing in oncology: Bridging computational discovery to clinical application18
Thoracic radiotherapy synergizes with first‐line EGFRTKIs in advanced 18
Tumor‐Regional Immune Microenvironment: A Critical Factor in the Design of Radiotherapy–Immunotherapy Combination Trials18
Late toxicity comparison of alkylating‐based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical tri18
Neuro–astrocytic network in breast cancer brain metastases: Adaptive mechanisms and novel therapeutic targets18
Naxitamab with novel scheduling and stepped‐up dosing of GMCSF plus vaccine, but no myeloablati18
Pioneering sustainable treatment delivery in childhood leukemia through synchronous telemedicine—A pilot study18
DNA methylation biomarkers for cervical cancer risk prediction in HIV‐positive Nigerian women18
Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO‐study18
Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS18
Correction to “Natural resistance to cancer: A window of hope”17
Antibodies against high‐risk human papillomavirus proteins as markers for noncervical HPV‐related cancers in a Black South African population, according to HIV status17
17
Correction to “FHL 2 Expression by Cancer‐Associated Fibroblasts Promotes Metastasis and Angiogenesis in Lung Adenocarcinoma”17
The Circulating Cholangiocarcinoma Protein Biomarkers CRP and MASP2 Also Predict Gallbladder Cance17
Artificial Intelligence in Colonoscopy Surveillance for Lynch Syndrome: Emerging Evidence, Lessons Learned From Average‐Risk Populations, and Future Directions17
17
Comprehensive analysis of a real‐world cohort identifies geranylgeranyl diphosphate synthase 1 as a predictor of chemoresistance in small cell lung cancer17
Training and validation of a novel 14‐gene expression signature associated with prostate cancer metastasis and postoperative recurrence17
Issue Information17
Plasma fatty acids depletion: A metabolic signature related to colon cancer17
Peri‐weaning cholera toxin consumption suppresses chemically‐induced carcinogenesis in mice17
Pierre Chambon17
Issue Information17
Associations between early‐life and in utero infections and cytomegalovirus‐positive acute lymphoblastic leukemia in children17
Impact of cancer and other causes of death on mortality of cancer patients: A study based on Japanese population‐based registry data17
17
17
Chronic acidosis rewires cancer cell metabolism through PPARα signaling17
Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315)17
Performance of visual inspection, partial genotyping, and their combination for the triage of women living with HIV who are screen positive for human papillomavirus: Results from the AIMA‐CC ANRS 123717
Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database17
Issue Information17
Comments on “Risk factors for low‐risk prostate cancer: A retrospective cohort study within the FinRSPC trial”16
Fragility Index analysis for robustness of evidence in Randomized Controlled Trials in National Comprehensive Cancer Network (NCCN) guidelines for rectal cancer16
16
Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology 16
Recent trends in hereditary breast cancer incidence by race and age in KwaZulu‐Natal, South Africa: An 11‐year single‐centre retrospective study (2011‐2021)16
Tissue‐resident memory T cells in immunotherapy and immune‐related adverse events by immune checkpoint inhibitor16
Home‐based self‐sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self‐Swab Study16
Clinical and genetic features of multiple primary tumours cohorts with a renal cell carcinoma: Implications for molecular genetic investigations16
Comparison of human papillomavirus‐based cervical cancer screening strategies in Tanzania among women with and without HIV16
Association between family history with lung cancer incidence and mortality risk in the Asia Cohort Consortium16
Association between serum urea concentrations and the risk of colorectal cancer, particularly in individuals with type 2 diabetes: A cohort study16
High‐risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 202016
Discovery of biomarkers in the era of radioimmunotherapy against lung cancer: A bench‐to‐bedside promise16
Response to: Comments on “Epidemiological trends and survival of oropharyngeal cancer in a high HPV ‐prevalent area: A Danish population‐based study 16
Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus16
DPYD and UGT1A1 Genotype‐Based Dosing for Fluoropyrimidines and Irinotecan Chemotherapy: Variant‐Specific Impact on Treatment 16
Head‐to‐head comparison of the diagnostic value of fecal and serum carcinoembryonic antigen for colorectal cancer detection16
Early‐Life Exposures and Risk of Multiple Myeloma: A Population‐Based Case–Control Study in Australia16
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth15
Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests15
Washed microbiota transplantation alleviates tyrosine kinase inhibitors associated gastrointestinal adverse effects15
Inhibition of the Rho / MRTF pathway improves the response of BRAF 15
Issue Information15
Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival15
Progesterone receptor ( PR ) intra‐tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial15
Serum 25‐hydroxyvitamin D, vitamin D‐related variants, and risk of chronic liver disease15
15
Assessing the risk of cervical neoplasia in the post‐HPV vaccination era15
Issue Information15
Adult T‐cell leukemia/lymphoma in French Guiana (1990–2019): Epidemiology, clinical features, and HTLV ‐1 genetic diversity in the two main ethnic po15
Neoadjuvant chemotherapy with docetaxel, oxaliplatin, and S‐1 versus oxaliplatin and S‐1 for locally advanced gastric adenocarcinoma: A multicenter, real‐world cohort study15
Enhancing breast cancer knowledge and clinical breast examination skills among healthcare providers at the polyclinics in Misrata, Libya15
Familial aggregation of early‐onset cancers in early‐onset breast cancer families15
Developing evidence‐based cancer prevention recommendations: Methodology of the World Code Against Cancer Framework to create region‐specific codes15
Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms15
Removal of gemcitabine‐induced senescent cancer cells by targeting glutaminase1 improves the therapeutic effect in pancreatic ductal adenocarcinoma14
0.79210686683655